Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01898611 · ClinicalTrials.gov registry record · Phase 2
Ghrelin Plus Strength Training in Frail Elderly Study
A Phase 2 study of Frailty Syndrome, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT01898611 is a Phase 2 study of Frailty Syndrome that has completed, run by University of Pennsylvania. The registered enrollment target is 16 participants, below the 334-participant average among 4 other Frailty Syndrome trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01898611, a Phase 2 study of Frailty Syndrome, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
Frailty is a geriatric syndrome leading to physical deterioration including muscle wasting (sarcopenia) and unintentional weight loss. There are currently no approved therapies for frailty. Ghrelin is a hormone produced by the stomach that stimulates appetite centers in the brain. The investigators already know that a single dose of Ghrelin improves food intake immediately after the dose in frail older people. In addition, exercise programs have been shown to improve strength and function in older people. In this study, the investigators are trying to find out if a joint intervention of ghrelin and resistance training will improve walking, balance and leg strength in frail elderly people.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ghrelin
Study Locations (1)
Pennsylvania
- Clinical and Translational Research Center, University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2013-07-01 |
| Est. Completion | 2016-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01898611
The ClinicalTrials.gov registry entry for NCT01898611 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 334-participant average among 4 other Frailty Syndrome trials with a reported enrollment target (95% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Frailty Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01898611 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01898611 about?
NCT01898611 is a clinical study titled "Ghrelin Plus Strength Training in Frail Elderly Study". Frailty is a geriatric syndrome leading to physical deterioration including muscle wasting (sarcopenia) and unintentional weight loss. There are currently no approved therapies for frailty. Ghrelin is a hormone produced by the stomach that stimulates appetite centers in the brain. The investigators ...
What is the current status of trial NCT01898611?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2013-07-01. Estimated completion is 2016-08-31.
What conditions does trial NCT01898611 study?
This clinical trial studies the following conditions: Frailty Syndrome.
What interventions are being tested in trial NCT01898611?
The interventions under investigation include: Placebo (DRUG), Ghrelin (DRUG).
Who is sponsoring clinical trial NCT01898611?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01898611 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Frailty Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Structured Program of Exercise for Recipients of Kidney Transplantation
RECRUITING · NA
-
COVID-19 Outcome Prediction Algorithm
RECRUITING
-
Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies
RECRUITING · NA
-
Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.